Impact of Sleep Apnea, Daytime Sleepiness, Comorbidities, and Depression on Patients' Heart Failure Health Status.
Ubolrat Piamjariyakul, April L Shapiro, Kesheng Wang and 4 others
PMID 33978519WHAT IT FOUND
In 198 advanced heart failure patients, sleep apnea, daytime sleepiness, depression, and four or more comorbidities were linked to worse heart failure health status.
Nurses can note these factors, but this study does not show treating them improves status.
Key findings
01Among 198 advanced heart failure patients, sleep apnea, daytime sleepiness, depression, and four or more comorbidities were each associated with worse heart failure clinical health status.
02Depression was the only significant factor associated with worse physical and mental health status scores.
03Gender, age, race, and education showed no significant differences in any health status outcome.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This was a secondary analysis of baseline data from an original study, so the question was not the original primary aim. The analysis was cross-sectional, so it cannot show whether sleep apnea, daytime sleepiness, depression, or comorbidity burden came before or caused worse heart failure status. Sleep apnea timing, type, treatment, and adherence were unknown. All participants were hospitalized for advanced heart failure, so it says little about milder heart failure or outpatient care. Participants had to read and write English and could not have dementia or cognitive deficiency, so results may not apply to more impaired or non-English-speaking patients.
Declared interests
No conflicts were declared. The article is tagged as NIH extramural research support.
The easy way to misread this
Do not read these associations as proof that treating sleep apnea, daytime sleepiness, depression, or comorbidity burden improves heart failure health status. The study measured them at baseline and did not test treatment.